Profil
Alan R.
Meyer is the founder of OcuSub, Inc. (founded in 2002) and Ocuphire Pharma, Inc. (founded in 2018).
He holds the title of Director at OcuSub, Inc. and Director at Ocuphire Pharma, Inc. Mr. Meyer also held former positions as Director at Aksys Ltd.
and Chief Financial Officer & Executive Vice President at PathoGenesis Corp (from 1992 to 2000).
Mr. Meyer received his undergraduate degree from the University of Illinois and his MBA from Kellogg School of Management.
Aktive Positionen von Alan R. Meyer
| Unternehmen | Position | Beginn |
|---|---|---|
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Gründer | 01.01.2002 |
Ehemalige bekannte Positionen von Alan R. Meyer
| Unternehmen | Position | Ende |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Gründer | 07.06.2021 |
| AKSYS LTD. | Direktor/Vorstandsmitglied | 23.06.2006 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Finanzdirektor/CFO | 01.01.2000 |
Ausbildung von Alan R. Meyer
| University of Illinois | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AKSYS LTD. | Finance |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
